Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Harvesting Nanocatalytic Heat Localized in Nanoalloy Catalyst as a Heat Source in a Nanocomposite Thin Film Thermoelectric Device.

Zhao W, Shan S, Luo J, Mott DM, Maenosono S, Zhong CJ.

Langmuir. 2015 Oct 20;31(41):11158-63. doi: 10.1021/acs.langmuir.5b03193. Epub 2015 Oct 7.

PMID:
26444621
2.

Gold/Wüstite core-shell nanoparticles: suppression of iron oxidation through the electron-transfer phenomenon.

Singh P, Mott DM, Maenosono S.

Chemphyschem. 2013 Oct 7;14(14):3278-83. doi: 10.1002/cphc.201300471. Epub 2013 Aug 2.

PMID:
23913505
3.

Enhanced electronic properties of Pt@Ag heterostructured nanoparticles.

Dao AT, Mott DM, Higashimine K, Maenosono S.

Sensors (Basel). 2013 Jun 18;13(6):7813-26. doi: 10.3390/s130607813.

4.

Electronic transfer as a route to increase the chemical stability in gold and silver core-shell nanoparticles.

Mott DM, Anh DT, Singh P, Shankar C, Maenosono S.

Adv Colloid Interface Sci. 2012 Dec 1;185-186:14-33. doi: 10.1016/j.cis.2012.08.007. Epub 2012 Sep 4.

PMID:
22999044
5.

Chemical stabilization of gold coated by silver core-shell nanoparticles via electron transfer.

Shankar C, Dao AT, Singh P, Higashimine K, Mott DM, Maenosono S.

Nanotechnology. 2012 Jun 22;23(24):245704. doi: 10.1088/0957-4484/23/24/245704. Epub 2012 May 28.

PMID:
22641370
6.

Palmitate action to inhibit glycogen synthase and stimulate protein phosphatase 2A increases with risk factors for type 2 diabetes.

Mott DM, Stone K, Gessel MC, Bunt JC, Bogardus C.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E444-50. Epub 2007 Dec 4. Erratum in: Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E807.

7.

Palmitate oxidation rate and action on glycogen synthase in myoblasts from insulin-resistant subjects.

Mott DM, Hoyt C, Caspari R, Stone K, Pratley R, Bogardus C.

Am J Physiol Endocrinol Metab. 2000 Sep;279(3):E561-9.

8.

Functional analyses of amino acid substitutions Arg883Ser and Asp905Tyr of protein phosphatase-1 G-subunit.

Permana PA, Kahn BB, Huppertz C, Mott DM.

Mol Genet Metab. 2000 Jun;70(2):151-8.

PMID:
10873397
9.
11.
12.

Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians.

Majer M, Mott DM, Mochizuki H, Rowles JC, Pedersen O, Knowler WC, Bogardus C, Prochazka M.

Diabetologia. 1996 Mar;39(3):314-21.

PMID:
8721777
13.

Immunoreactive glycogen-binding subunit of protein phosphatase-1 in human skeletal muscle.

Nyomba BL, Mott DM.

J Clin Endocrinol Metab. 1994 Aug;79(2):485-8.

PMID:
8045967
14.

Trypsin-Mn(2+)-resistant form of type 1 protein phosphatase in human muscle.

Mori H, Stone K, Mott DM.

Am J Physiol. 1994 Apr;266(4 Pt 1):E574-82.

PMID:
8178978
15.
16.

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.

Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C.

N Engl J Med. 1993 Dec 30;329(27):1988-92.

17.

Insulinemia in children at low and high risk of NIDDM.

Pettitt DJ, Moll PP, Knowler WC, Mott DM, Nelson RG, Saad MF, Bennett PH, Kottke BA.

Diabetes Care. 1993 Apr;16(4):608-15.

PMID:
8462388
18.

Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians.

Prochazka M, Lillioja S, Tait JF, Knowler WC, Mott DM, Spraul M, Bennett PH, Bogardus C.

Diabetes. 1993 Apr;42(4):514-9.

PMID:
8454101
19.

Tyrosine kinase activity of skeletal muscle during insulin infusion in humans.

Nyomba BL, Ossowski VM, Saad MF, Bogardus C, Mott DM.

J Clin Endocrinol Metab. 1992 Jul;75(1):218-23.

PMID:
1619013
20.

Defective insulin response of phosphorylase phosphatase in insulin-resistant humans.

Kida Y, Raz I, Maeda R, Nyomba BL, Stone K, Bogardus C, Sommercorn J, Mott DM.

J Clin Invest. 1992 Feb;89(2):610-7.

21.
22.

Basal and insulin-mediated carbohydrate metabolism in human muscle deficient in phosphofructokinase 1.

Katz A, Spencer MK, Lillioja S, Yan Z, Mott DM, Haller RG, Lewis SF.

Am J Physiol. 1991 Oct;261(4 Pt 1):E473-8.

PMID:
1833982
23.

Insulin-sensitive tyrosine kinase activity changes in parallel with plasma insulin and glucose concentrations in humans.

Nyomba BL, Swinburn BA, Ossowski VM, Boyce VL, Bogardus C, Mott DM.

J Clin Endocrinol Metab. 1991 Jun;72(6):1212-9.

PMID:
2026743
24.

Studies of the etiology of obesity in Pima Indians.

Howard BV, Bogardus C, Ravussin E, Foley JE, Lillioja S, Mott DM, Bennett PH, Knowler WC.

Am J Clin Nutr. 1991 Jun;53(6 Suppl):1577S-1585S. doi: 10.1093/ajcn/53.6.1577S.

PMID:
1827703
25.

Amylin activates glycogen phosphorylase in the isolated soleus muscle of the rat.

Young AA, Mott DM, Stone K, Cooper GJ.

FEBS Lett. 1991 Apr 9;281(1-2):149-51.

26.

Hyperglycemia induces accumulation of glucose in human skeletal muscle.

Katz A, Raz I, Spencer MK, Rising R, Mott DM.

Am J Physiol. 1991 Apr;260(4 Pt 2):R698-703.

PMID:
1672795
27.
28.

Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.

Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH.

Diabetes. 1990 Nov;39(11):1430-5.

PMID:
2227116
29.

Skeletal muscle glycogen synthase activity in subjects with non-insulin-dependent diabetes mellitus after glyburide therapy.

Nyomba BL, Freymond D, Raz I, Stone K, Mott DM, Bogardus C.

Metabolism. 1990 Nov;39(11):1204-10.

PMID:
2122177
30.

Insulin-sensitive tyrosine kinase: relationship with in vivo insulin action in humans.

Nyomba BL, Ossowski VM, Bogardus C, Mott DM.

Am J Physiol. 1990 Jun;258(6 Pt 1):E964-74.

PMID:
2163202
31.
32.

Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions.

Bogardus C, Lillioja S, Nyomba BL, Zurlo F, Swinburn B, Esposito-Del Puente A, Knowler WC, Ravussin E, Mott DM, Bennett PH.

Diabetes. 1989 Nov;38(11):1423-32.

PMID:
2695375
33.

Adenosine 3',5'-monophosphate-dependent protein kinase activity decreases in human muscle after insulin infusion.

Okubo M, Bogardus C, Lillioja S, Mott DM.

J Clin Endocrinol Metab. 1989 Oct;69(4):798-803.

PMID:
2506213
34.

Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes.

Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH.

Lancet. 1989 Jun 17;1(8651):1356-9.

PMID:
2567374
36.

The natural history of impaired glucose tolerance in the Pima Indians.

Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH.

N Engl J Med. 1988 Dec 8;319(23):1500-6.

PMID:
3054559
37.

Glucose-6-phosphate stimulation of human muscle glycogen synthase phosphatase.

Okubo M, Bogardus C, Lillioja S, Mott DM.

Metabolism. 1988 Dec;37(12):1171-6.

PMID:
2848177
38.

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C.

N Engl J Med. 1988 May 12;318(19):1217-25.

PMID:
3283552
39.
40.

Increased rate of Cori cycle in obese subjects with NIDDM and effect of weight reduction.

Zawadzki JK, Wolfe RR, Mott DM, Lillioja S, Howard BV, Bogardus C.

Diabetes. 1988 Feb;37(2):154-9.

PMID:
3391340
41.

Insulin response of components of whole-body and muscle carbohydrate metabolism in humans.

Young AA, Bogardus C, Stone K, Mott DM.

Am J Physiol. 1988 Feb;254(2 Pt 1):E231-6.

PMID:
3279804
42.

In vivo insulin action is familial characteristic in nondiabetic Pima Indians.

Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Knowler WC, Bennett PH, Moll P, Bogardus C.

Diabetes. 1987 Nov;36(11):1329-35.

PMID:
3311855
43.

Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance.

Lillioja S, Mott DM, Zawadzki JK, Young AA, Abbott WG, Bogardus C.

J Clin Endocrinol Metab. 1986 May;62(5):922-7.

PMID:
3514652
44.

Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man.

Mott DM, Lillioja S, Bogardus C.

Metabolism. 1986 Feb;35(2):160-5.

PMID:
3080654
45.

Insulin-resistant Na+ pump activity in adipocytes from obese humans.

Mott DM, Clark RL, Andrews WJ, Foley JE.

Am J Physiol. 1985 Aug;249(2 Pt 1):E160-4.

PMID:
2411146
46.

Relationship between insulin-mediated glucose disposal and lipid metabolism in man.

Lillioja S, Bogardus C, Mott DM, Kennedy AL, Knowler WC, Howard BV.

J Clin Invest. 1985 Apr;75(4):1106-15.

47.

Relationship between degree of obesity and in vivo insulin action in man.

Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G.

Am J Physiol. 1985 Mar;248(3 Pt 1):E286-91.

PMID:
3883799
49.

Altered insulin binding to monocytes and diploid fibroblasts from obese donors.

Mott DM, Howard BV, Savage PJ, Nagulesparan M.

J Clin Endocrinol Metab. 1983 Jul;57(1):1-7.

PMID:
6343414
50.

Reduced Na+, K+ -ATPase activity in intact red cells and isolated membranes from obese man.

Klimes I, Nagulesparan M, Unger RH, Aronoff SL, Mott DM.

J Clin Endocrinol Metab. 1982 Apr;54(4):721-4.

PMID:
6277981

Supplemental Content

Support Center